Pharma industry change – Sanofi

December 21, 2009 · Posted in Acquisitions and mergers, Pharma, strategy 

As if to emphasise what my last post said, today came an announcement from Sanofi, the French pharma company, that they are buying Chattem for $1.9bn. Chattem provides over-the-counter drugs like Gold Bond or Selsun Blue. Selsun Blue

What’s the rationale for this? Probably Sanofi wants to become less reliant on the blockbuster patented drug business.

Comments

Leave a Reply